1Sieben NL, Kolkman-Uljee SM, Flanagan AM,et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. AM J Pathol ,2003,162(4):1095-1101. 被引量：1
2Kayikcioglu F, Pata O, Cengiz S, et al. Accuracy of frozen-section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest, 2000,49(3):187. 被引量：1
3Houck K, Nikrui N, Duska L,et al. Borderline toumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol, 2000, 95(6):839. 被引量：1
4Fauvet R, Boccara J, Dutoumet C, et al. Restaging surgery for women with borderline ovarian tumors .Cancer, 2004,100:1145-1151. 被引量：1
5Camatte S, Moricc P, Thoury A, et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumors: analysis of a continuous serious of 101 cases . Eur J Cancer, 2004, 40(12):1842-1849. 被引量：1
6Makarewicz H, Emerich J, Olszewski J, et al. Pregnancy and delivery after conservative taeatment of borderline ovarian tumor with FIGO stage case report. Ginekol Pol,2002,73(3):225. 被引量：1
7Camatte S, Morice P, Pautier P, et al. Fertility results after conservative treatment of advanced stage serous borderline tumor of the ovary. BJOG, 2002,109(4):376-380. 被引量：1
8Nurettin B, Aylin P, Gokhan T, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors . Gynecol Oncol,2005,97(3):845. 被引量：1
9Morice P, Camatte S, El Hassan J,et al Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril,2001,75(1):92-96. 被引量：1
10Camatte S, Morice P, Atallah D, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. Am Coll Surg, 2002,195(3):332. 被引量：1
